These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 526320)

  • 1. Physico-chemical properties of tumor cells that influence their susceptibility to humoral immune killing.
    Schlager SI; Ohanian SH
    Biochem Biophys Res Commun; 1979 Dec; 91(4):1512-20. PubMed ID: 526320
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of hormones on the killing by antibody and complement of tumor cells treated with proteolytic enzymes.
    Schlager SI; Ohanian SH; Borsos T
    Immunopharmacology; 1979 Mar; 1(2):115-24. PubMed ID: 400472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma membrane and intracellular lipid synthesis in tumor cells rendered resistant to humoral immune killing after treatment with hormones.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1980 Apr; 64(4):943-50. PubMed ID: 6988626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma membrane and intracellular lipid synthesis in tumor cells rendered sensitive to humoral immune killing after treatment with metabolic inhibitors.
    Schlager SI; Ohanian SH
    J Natl Cancer Inst; 1979 Dec; 63(6):1475-83. PubMed ID: 292816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the intracellular cyclic adenosine 3':5'-monophosphate level of tumor cells and their sensitivity to killing by antibody and complement.
    Lo TN; Boyle MD
    Cancer Res; 1979 Aug; 39(8):3156-62. PubMed ID: 222445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.
    Schlager SI; Ohanian SH; Borsos T
    J Natl Cancer Inst; 1978 Sep; 61(3):931-4. PubMed ID: 278869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell lipid composition and sensitivity to humoral immune killing. I. Modification of cellular lipid and fatty acid content by metabolic inhibitors and hormones.
    Schlager SI; Ohanian SH
    J Immunol; 1980 Feb; 124(2):626-34. PubMed ID: 6243329
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancing effect by metabolic inhibitors on the killing of tumor cells by antibody and complement.
    Segerling M; Ohanian SH; Borsos T
    Cancer Res; 1975 Nov; 35(11 Pt 1):3195-203. PubMed ID: 52404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of antibody-complement-mediated killing of tumor cells by hormones.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1976 Oct; 36(10):3672-7. PubMed ID: 182362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipids, structural precursors of lipids and fatty acids on complement-mediated killing of antibody-sensitized nucleated cells.
    Ohanian SH; Schlager SI; Saha S
    Mol Immunol; 1982 Apr; 19(4):535-42. PubMed ID: 7087963
    [No Abstract]   [Full Text] [Related]  

  • 11. A role for fatty acid composition of complex cellular lipids in the susceptibility of tumor cells to humoral immune killing.
    Schlager SI; Ohanian SH
    J Immunol; 1979 Jul; 123(1):146-52. PubMed ID: 448144
    [No Abstract]   [Full Text] [Related]  

  • 12. Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.
    Ohanian SH; Schlager SI
    Crit Rev Immunol; 1981 Jan; 1(3):165-209. PubMed ID: 6174273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of specific phospholipids on the antibody-complement-mediated killing of nucleated cells.
    Ohanian SH; Schlager SI; Yamazaki M; Ishida B
    J Immunol; 1979 Sep; 123(3):1014-9. PubMed ID: 469242
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.
    Schlager SI; Boyle MD; Ohanian SH; Borsos T
    Cancer Res; 1977 May; 37(5):1432-7. PubMed ID: 192450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell lipid composition and sensitivity to humoral immune killing. II. Influence of plasma membrane and intracellular lipid and fatty acid content.
    Schlager SI; Ohanian SH
    J Immunol; 1980 Aug; 125(2):508-17. PubMed ID: 7391566
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of hormone-induced tumor cell resistance to killing by antibody and complement.
    Schlager SI; Ohanian SH; Borsos T
    Cancer Res; 1977 Mar; 37(3):765-70. PubMed ID: 189914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and chemical composition of subcellular fractions from tumor cells treated with metabolic inhibitors or hormones.
    Schlager SI; Ohanian SH
    Cancer Res; 1979 Apr; 39(4):1369-76. PubMed ID: 421220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune responses to tumor-specific antigens in strain-2 guinea pigs.
    Smith HG; Leonard EJ
    J Natl Cancer Inst; 1974 Jul; 53(1):187-94. PubMed ID: 4366195
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic requirements for hormone-induced resistance to antibody-complement mediated killing of tumor cells.
    Schlager SI; Ohanian SH; Borsos T
    J Immunol; 1977 Sep; 119(3):789-94. PubMed ID: 894026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.
    Okada H; Tanaka H; Okada N
    Immunology; 1983 May; 49(1):29-35. PubMed ID: 6301976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.